Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_assertion type Assertion NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_head.
- NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_assertion description "[Despite recent discoveries made in myeloproliferative disorders other than chronic myelogenous leukemia, which it is hoped will result in earlier diagnosis, and better evaluation and management of patients, hematological evolution to myelofibrosis, acute leukemia, and myelodysplastic syndromes (AL/MDS) remain major causes of long-term mortality in polycythemia vera (PV) and essential thrombocythemia (ET) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_provenance.
- NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_assertion evidence source_evidence_literature NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_provenance.
- NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_assertion SIO_000772 16810617 NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_provenance.
- NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_assertion wasDerivedFrom befree-20150227 NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_provenance.
- NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_assertion wasGeneratedBy ECO_0000203 NP873221.RADK2IOrSM69RUz_f2gub96-wGraEQ_HKfkc-sFeARwko130_provenance.